SQSTM1/p62 Regulate Breast Cancer Progression and Metastasis by Inducing Cell Cycle Arrest and Regulating Immune Cell Infiltration
Overview
Affiliations
The autophagy adaptor protein SQSTM1/p62 is overexpressed in breast cancer and has been identified as a metastasis-related protein. However, the mechanism by which SQSTM1/p62 contributes to breast cancer progression and tumor microenvironment remains unclear. This study revealed that silencing expression suppressed breast cancer progression via regulating cell proliferation and reshaping the tumor microenvironment (TME). Here, we found that SQSTM1/62 was overexpressed in multiple human cancer tissue types and that was correlated with poor patient overall survival (OS) and disease-free survival (DFS). Moreover, we found that short-hairpin RNA (shRNA)-mediated knockdown of expression significantly inhibited cell proliferation, migration, and invasion, and promoted cell death , as well as suppressed breast cancer growth and lung metastasis . In addition, flow cytometry analysis of splenocytes and tumor infiltrating lymphocytes (TILs) indicated that the numbers of CD8α interferon (IFN)-γ cells (CTLs) and CD4IFN-γ (Th1) cells were increased while those of CD4IL-4 (Th2) cells, tumor-associated macrophages (TAMs) and myeloid-derived suppressor cells (MDSCs) were decreased. RT-PCR analyses showed that the gene expression of Th1/Th2 cytokines changed in the tumor microenvironment. Silencing /62 suppressed tumor cell lung metastasis. Together, our results provide strong evidence that silencing tumor cell /62 inhibited tumor growth and metastasis through cell cycle arrest and TME regulation. This finding provides a novel molecular therapeutic strategy for breast cancer progression and metastasis treatment.
Recent advances in the role of high-salt diet in anti- and pro-cancer progression.
Tang S, Xu J, Wan P, Jin S, Zhang Y, Xun L Front Immunol. 2025; 16:1542157.
PMID: 39944693 PMC: 11814453. DOI: 10.3389/fimmu.2025.1542157.
Dahl-Wilkie H, Gomez J, Kelley A, Manjit K, Mansoor B, Kanumuri P Cells. 2025; 14(3).
PMID: 39936983 PMC: 11816438. DOI: 10.3390/cells14030192.
Liu W, Huang Y, Xu Y, Gao X, Zhao Y, Fan S Front Chem. 2024; 12:1484310.
PMID: 39600313 PMC: 11591233. DOI: 10.3389/fchem.2024.1484310.
Current state of research on copper complexes in the treatment of breast cancer.
Hu K, Guo J, Zeng J, Shao Y, Wu B, Mo J Open Life Sci. 2024; 19(1):20220840.
PMID: 38585632 PMC: 10997149. DOI: 10.1515/biol-2022-0840.
Li Y, Liu J, Yao D, Guo Z, Jiang X, Zhang C Arch Toxicol. 2024; 98(5):1369-1381.
PMID: 38485781 DOI: 10.1007/s00204-024-03709-2.